Institutional Ownership
Evaxion Biotech A/S
CUSIP 29970R204COMEVAXUSDQ1 2026
13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
4 filings · latest Feb 3, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Merck & Co., Inc. | 1.21M | $4.52M |